Clinical importance of biocompatibility and its effect on haemodialysis treatment

被引：26
作者：
Opatrny, K [1 ]
机构：
[1] Charles Univ, Sch Med, Dept Med 1, Plzen, Czech Republic
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2003年 / 18卷
关键词：
biocompatibility; bradykinin; complement; ethylene oxide; perfluorohydrocarbon; thrombogenicity;
D O I：
10.1093/ndt/gfg1044
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：41 / 44
页数：4
相关论文
共 15 条
[1]   Relationship of dialysis membrane and cause-specific mortality [J].
Bloembergen, WE ;
Hakim, RM ;
Stannard, DC ;
Held, PJ ;
Wolfe, RA ;
Agodoa, LYC ;
Port, FK .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 33 (01) :1-10
[2]   Performance liquid test as a cause for sudden deaths of dialysis patients: perfluorohydrocarbon, a previously unrecognized hazard for dialysis patients [J].
Canaud, B .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 (04) :545-548
[3]   COMPLEMENT AND LEUKOCYTE-MEDIATED PULMONARY DYSFUNCTION IN HEMODIALYSIS [J].
CRADDOCK, PR ;
FEHR, J ;
BRIGHAM, KL ;
KRONENBERG, RS ;
JACOB, HS .
NEW ENGLAND JOURNAL OF MEDICINE, 1977, 296 (14) :769-774
[4]  
Eknoyan G, 2002, J AM SOC NEPHROL, V13, p421A
[5]  
Himmelfarb J, 1998, J AM SOC NEPHROL, V9, P257
[6]   BIOCOMPATIBILITY - THE NEED FOR A SYSTEMS-APPROACH [J].
KLINKMANN, H ;
IVANOVICH, P ;
FALKENHAGEN, D .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1993, 8 :40-42
[7]  
KUMMERLE W, 1998, BLOOD MAT INTERACTIO, P100
[8]   A clinical study to assess the effect of heparin in dialyzer rinsing solutions [J].
Opatrny, K ;
Bouda, M ;
Kohoutkova, L ;
Vit, L ;
Sefrna, F .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1997, 20 (02) :112-118
[9]   CLINICAL-STUDY OF HIGH-FLUX CUPRAMMONIUM RAYON HEMODIALYSIS MEMBRANES [J].
OPATRNY, K ;
SULKOVA, S ;
LOPOT, F ;
VIT, L ;
VALEK, A ;
OPATRNY, K .
ARTIFICIAL ORGANS, 1993, 17 (12) :971-976
[10]   Activation of the kallikrein-kinin system in hemodialysis: Role of membrane electronegativity, blood dilution, and pH [J].
Renaux, JL ;
Thomas, M ;
Crost, T ;
Loughraieb, N ;
Vantard, G .
KIDNEY INTERNATIONAL, 1999, 55 (03) :1097-1103
12